About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02350907

Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea

The purpose of this study is to develop a laboratory-based assay that will be a real-time PCR test to detect the organism N. gonorrhoeae and its most important genetic markers of antimicrobial resista...

Lead sponsor: University of Bern•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Bern

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participant is willing and able to give informed consent for participation in the study.
•Male or female, aged 18 years or above.
•Participant is literate in German, French, English or Hungarian.
•Participant is at risk for a N. gonorrhoeae infection. This is defined as:
•1. exhibiting signs/symptoms of a N. gonorrhoeae infection.
•2. having a sexual partner who has been diagnosed with a N. gonorrhoeae infection.
•3. participating in high-risk activities for a N. gonorrhoeae infection.

Exclusion Criteria

•Subject does not agree to undergo diagnostic test for gonorrhoea.

Related studies

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

NCT06369220 · Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, and more

COMPLETEDPhase 1

Optimizing Strategies to Improve STD Partner Services

NCT00207454 · Chlamydia Trachomatis, Neisseria Gonorrhoeae

COMPLETEDPhase 2

Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

NCT04722003 · Gonorrhoea

Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)

NCT05581160 · Sexually Transmitted Infections (Not HIV or Hepatitis), Chlamydia Trachomatis Infection, and more

Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs

NCT03596151 · Chlamydial Infection, Gonorrhoea, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 16, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment261

Start dateFeb 2015

Last updatedJul 16, 2019

Condition

Locations shown

University Hospital of Bern

Bern

Ambulatorium Kanonengasse

Zurich

Checkpoint Zurich

Zurich

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions